Caitong International Asset Management Co., LTD Altimmune, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Altimmune, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 24,336 shares of ALT stock, worth $155,020. This represents 0.17% of its overall portfolio holdings.
Number of Shares
24,336
Previous 24,336
-0.0%
Holding current value
$155,020
Previous $175 Million
-0.0%
% of portfolio
0.17%
Previous 0.17%
Shares
1 transactions
Others Institutions Holding ALT
# of Institutions
204Shares Held
39.7MCall Options Held
1.8MPut Options Held
1.04M-
Black Rock Inc. New York, NY5.32MShares$33.9 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN5.25MShares$33.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$28.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.47MShares$22.1 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$17.5 Million1.49% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $312M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...